Ginna S. Eynon, PharmD Candidate 2026 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 29-year-old female with a history of schizophrenia and depression was referred for a pharmacotherapy evaluation by her social work case manager. During a recent …
Read More »Tirzepatide: A Dual GLP-1/GIP Receptor Agonist for the Treatment of T2D
Authors: Ashley Wagnild, PharmD Candidate 2024, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 54-year-old man was referred to the pharmacotherapy clinic by his primary care provider (PCP) for a therapy consult. The patient had a past medical …
Read More »The Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone: A New Option for Patients with Diabetic Kidney Disease
Allison S. Rembert, PharmD Candidate 2024 Adrian K. Baker, PharmD Candidate 2024 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 55-year-old female with type 2 diabetes (T2D) and chronic kidney disease (CKD) presented to the ambulatory care clinic. …
Read More »Don’t Blame All Symptoms on Glucose Levels
A woman, 72 years of age, type 2 diabetes, obesity, taking metformin, GLP1, ARB, and antidepressant (SSRI). Lost 20% total body weight in the past year. Recently complaining of dizziness and weakness. Glucose levels in the 60’s at home, at which time had symptoms of hypoglycemia. Glucose-lowering medications (metformin and GLP-1) were stopped. Continued to complain of dizziness and weakness especially in the morning.
Read More »Don’t Be So Quick to Stop a Treatment That’s Working
Man, 52 years of age, type 2 diabetes, obesity class II on Victoza. He was very pleased with treatment response, lowering glucose levels, feeling full and more satisfied, but having a skin reaction.
Read More »Dosing Error Due to Misinterpretation
When reviewing the medical record of a hospital patient before meeting with her for a diabetes consult, I noted that the doctor had ordered 46 units of Lantus to be given daily at bedtime....
Read More »Know the Side Effects of the Drugs You Prescribe
Male, 72 years of age, type 2, insulin-requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of the workday, glucose elevated much higher than the reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy....
Read More »Prevent Infection Transmission During Assisted Glucose Monitoring
Several warnings have been issued by the CDC regarding unsafe practices that might result in the transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and other infectious diseases during assisted blood glucose monitoring and insulin administration.
Read More »Mail-Order Mix-Up
During a recent phone follow-up call to one of my patients, a co-worker and I avoided a "Diabetes Disaster." My patient told me that she had received her mail-order refill for "ASPART," but the bottle didn't look the same....
Read More »In Search for Culprit Behind Glucose Swings, Investigate Non-diabetes Medications
Recently I had a patient who was referred to me due to increased glucose levels, which happens all the time. However, this patient was referred because of the recent changes in fasting glucose levels. After attending a group diabetes class, the patient seemed to be improving self care and average fasting glucoses had dropped from around 165 mg/dl to 130 mg/dl. The readings held like this for two months and then started to rise again....
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.